Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Gkika, E; Adebahr, S; Kirste, S; Schimek-Jasch, T; Wiehle, R; Claus, R; Wittel, U; Nestle, U; Baltas, D; Grosu, AL; Brunner, TB.
Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer : A toxicity review of simultaneous integrated protection (SIP) versus conventional SBRT.
Strahlenther Onkol. 2017; 193(6):433-443
Doi: 10.1007/s00066-017-1099-8
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Brunner Thomas Baptist
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BACKGROUND: Stereotactic body radiotherapy (SBRT) in pancreatic cancer can be limited by its proximity to organs at risk (OAR). In this analysis, we evaluated the toxicity and efficacy of two different treatment approaches in patients with locally recurrent or oligometastatic pancreatic cancer. MATERIALS AND METHODS: According to the prescription method, patients were divided in two cohorts (C1 and C2). The planning target volume (PTV) was created through a 4 mm expansion of the internal target volume. In C2, a subvolume was additionally created, a simultaneous integrated protection (SIP), which is the overlap of the PTV with the planning risk volume of an OAR to which we prescribed a reduced dose. RESULTS: In all, 18 patients were treated (7 with local recurrences, 9 for oligometastases, 2 for both). Twelve of 23 lesions were treated without SIP (C1) and 11 with SIP (C2). The median follow-up was 12.8 months. Median overall survival (OS) was 13.2 (95% confidence interval [CI] 9.8-14.6) months. The OS rates at 6 and 12 months were 87 and 58%, respectively. Freedom from local progression for combined cohorts at 6 and 12 months was 93 and 67% (95% CI 15-36), respectively. Local control was not statistically different between the two groups. One patient in C2 experienced grade ≥3 acute toxicities and 1 patient in C1 experienced a grade ≥3 late toxicity. CONCLUSION: The SIP approach is a useful prescription method for abdominal SBRT with a favorable toxicity profile which does not compromise local control and overall survival despite dose sacrifices in small subvolumes.
- Find related publications in this database (using NLM MeSH Indexing)
- Adenocarcinoma - mortality, pathology, radiotherapy
- Adult - administration & dosage
- Aged - administration & dosage
- Cohort Studies - administration & dosage
- Combined Modality Therapy - administration & dosage
- Disease Progression - administration & dosage
- Female - administration & dosage
- Humans - administration & dosage
- Magnetic Resonance Imaging - administration & dosage
- Male - administration & dosage
- Middle Aged - administration & dosage
- Neoplasm Metastasis - administration & dosage
- Neoplasm Recurrence, Local - mortality, radiotherapy, surgery
- Neoplasm Staging - administration & dosage
- Organs at Risk - radiation effects
- Pancreatic Neoplasms - mortality, pathology, radiotherapy, surgery
- Positron Emission Tomography Computed Tomography - administration & dosage
- Radiation Protection - methods
- Radiosurgery - methods
- Radiotherapy Dosage - administration & dosage
- Radiotherapy Planning, Computer-Assisted - administration & dosage
- Radiotherapy, Adjuvant - methods
- Radiotherapy, Intensity-Modulated - methods
- Retrospective Studies - administration & dosage
- Survival Analysis - administration & dosage
- Tomography, X-Ray Computed - administration & dosage
- Find related publications in this database (Keywords)
- Local progression
- Radiation therapy
- Overall survival
- Prognosis
- Toxicity